Moolec Science SA (NASDAQ:MLEC) Short Interest Update

Moolec Science SA (NASDAQ:MLEC) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 7,508 shares, a drop of 93.4% from the April 30th total of 114,402 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average trading volume of 36,259 shares, the short-interest ratio is presently 0.2 days.

Moolec Science Price Performance

MLEC stock traded down $0.18 during trading on Wednesday, hitting $7.25. 6,855 shares of the stock traded hands, compared to its average volume of 990,267. Moolec Science has a one year low of $3.08 and a one year high of $126.60. The stock has a market cap of $5.29 million, a price-to-earnings ratio of -0.22 and a beta of 0.38. The company has a 50 day simple moving average of $8.09 and a 200 day simple moving average of $7.59. The company has a current ratio of 0.15, a quick ratio of 0.08 and a debt-to-equity ratio of 0.79.

Moolec Science (NASDAQ:MLEC) last posted its quarterly earnings data on Thursday, May 14th. The company reported $47.49 earnings per share for the quarter. The company had revenue of $2.62 million during the quarter.

Institutional Investors Weigh In On Moolec Science

A hedge fund recently bought a new stake in Moolec Science stock. Citadel Advisors LLC acquired a new stake in Moolec Science SA (NASDAQ:MLEC) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 36,218 shares of the company’s stock, valued at approximately $36,000. Citadel Advisors LLC owned approximately 0.90% of Moolec Science at the end of the most recent quarter. Hedge funds and other institutional investors own 0.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Moolec Science from a “sell” rating to a “hold” rating in a report on Saturday, May 16th.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.